Shares of Pfizer offer a yield above 7% at recent prices. Pfizer is a pharmaceutical giant that has raised its dividend every ...

Lululemon has sued Costco, alleging the retailer sells low-cost athleisure apparel knockoffs that unlawfully infringe ...

Oprah Winfrey and Elon Musk endorsed it. And though Indian celebrities haven’t yet admitted to their use, the mystery ...

Pfizer's innovative business should grow faster after it divests its off-patent division Upjohn in 2020 to create Viatris and Mylan. With fewer older medications and fewer patent losses, Pfizer is ...

Lowering prescription drug costs across the board will need the help of Congress, former Norfolk School Board member Yvonne ...

Phathom: Share Price Surge On Patent News May Not Stop The Rot For Long Jun. 09, 2025 12:37 PM ET Phathom Pharmaceuticals, Inc. (PHAT) Stock PHAT 19 Comments Edmund Ingham Investing Group Leader ...

Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...

The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...

Although Merck (NYSE:MRK) is confronted with the unavoidable Keytruda patent cliff in 2028, the company is strategically ...

Pfizer offers a high 7.4% dividend yield and trades at low valuation multiples. Click here to read more about PFE stock and why it is a Buy.

Bone Biologics filed a USPTO patent for NELL-1 and announced a $5 million offering to support trials and expand its bone regeneration patent portfolio.